Whitehawk Therapeutics Files 8-K on Shareholder Vote

Ticker: WHWK · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1422142

Whitehawk Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyWhitehawk Therapeutics, INC. (WHWK)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, filing-update

TL;DR

Whitehawk (formerly Aadi) had a shareholder vote on 6/11. 8-K filed 6/13.

AI Summary

Whitehawk Therapeutics, Inc. filed an 8-K on June 13, 2025, reporting on a matter submitted to a vote of security holders on June 11, 2025. The company, formerly known as Aadi Bioscience, Inc. and Aerpio Pharmaceuticals, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing indicates a formal process where shareholders are being asked to vote on a specific corporate matter, which could impact the company's direction or governance.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.

Key Numbers

Key Players & Entities

FAQ

What specific matter was submitted for a vote by Whitehawk Therapeutics' security holders on June 11, 2025?

The filing does not specify the exact matter submitted for a vote, only that a submission of matters to a vote of security holders occurred on June 11, 2025.

When was the 8-K report officially filed with the SEC?

The 8-K report was filed as of date June 13, 2025.

What are the former names of Whitehawk Therapeutics, Inc. mentioned in the filing?

The filing lists former company names as Aadi Bioscience, Inc. (name change date 20210826) and Aerpio Pharmaceuticals, Inc. (name change date 20170316).

In which state is Whitehawk Therapeutics, Inc. incorporated?

Whitehawk Therapeutics, Inc. is incorporated in Delaware.

What is the primary business sector for Whitehawk Therapeutics, Inc. according to the filing?

The company's Standard Industrial Classification (SIC) is Pharmaceutical Preparations [2834].

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Whitehawk Therapeutics, Inc. (WHWK).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing